Skip to Content
Merck

Metformin as adjunct antituberculosis therapy.

Science translational medicine (2014-11-21)
Amit Singhal, Liu Jie, Pavanish Kumar, Gan Suay Hong, Melvin Khee-Shing Leow, Bhairav Paleja, Liana Tsenova, Natalia Kurepina, Jinmiao Chen, Francesca Zolezzi, Barry Kreiswirth, Michael Poidinger, Cynthia Chee, Gilla Kaplan, Yee Tang Wang, Gennaro De Libero
ABSTRACT

The global burden of tuberculosis (TB) morbidity and mortality remains immense. A potential new approach to TB therapy is to augment protective host immune responses. We report that the antidiabetic drug metformin (MET) reduces the intracellular growth of Mycobacterium tuberculosis (Mtb) in an AMPK (adenosine monophosphate-activated protein kinase)-dependent manner. MET controls the growth of drug-resistant Mtb strains, increases production of mitochondrial reactive oxygen species, and facilitates phagosome-lysosome fusion. In Mtb-infected mice, use of MET ameliorated lung pathology, reduced chronic inflammation, and enhanced the specific immune response and the efficacy of conventional TB drugs. Moreover, in two separate human cohorts, MET treatment was associated with improved control of Mtb infection and decreased disease severity. Collectively, these data indicate that MET is a promising candidate host-adjunctive therapy for improving the effective treatment of TB.

MATERIALS
Product Number
Brand
Product Description

Supelco
Rapamycin, VETRANAL®, analytical standard
Supelco
Streptomycin solution, ~1 mg/mL in 1 mM EDTA, analytical standard
Supelco
Isoniazid, analytical standard, ≥99% (TLC)
Sigma-Aldrich
Nitrendipine, >95%, powder
Sigma-Aldrich
RIPA Buffer
USP
Verapamil hydrochloride, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
(S)-(−)-Bay K8644, ≥98% (HPLC), solid
Sigma-Aldrich
Nimodipine
Sigma-Aldrich
Streptomycin Ready Made Solution, 100 mg/mL in water
Didanosine impurity G, European Pharmacopoeia (EP) Reference Standard
Supelco
Nimodipine, Pharmaceutical Secondary Standard; Certified Reference Material
Nimodipine, European Pharmacopoeia (EP) Reference Standard
Verapamil hydrochloride, European Pharmacopoeia (EP) Reference Standard
Supelco
Hydrogen peroxide solution, ≥30%, for trace analysis
Sigma-Aldrich
Hydrogen peroxide solution, 34.5-36.5%
Sigma-Aldrich
Hydrogen peroxide solution, contains potassium stannate as inhibitor, 30-32 wt. % in water, semiconductor grade, 99.999% trace metals basis
Millipore
Hydrogen peroxide solution, 3%, suitable for microbiology
Sigma-Aldrich
1,1-Dimethylbiguanide hydrochloride, 97%
Sigma-Aldrich
Diethyl azodicarboxylate solution, 40 wt. % in toluene
Sigma-Aldrich
FPL 64176, ≥98% (HPLC), powder
Sigma-Aldrich
Hydrogen peroxide solution, 30 % (w/w) in H2O, contains stabilizer
Sigma-Aldrich
Streptomycin sulfate salt, powder
Sigma-Aldrich
Streptomycin sulfate salt, powder, BioXtra, suitable for mouse embryo cell culture
Sigma-Aldrich
Streptomycin sulfate salt, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
Ethionamide
Sigma-Aldrich
2′,3′-Dideoxyadenosine, ≥97% (HPLC)
Sigma-Aldrich
Hydrogen peroxide solution, tested according to Ph. Eur.
Supelco
Loperamide hydrochloride, VETRANAL®, analytical standard
Loperamide hydrochloride, European Pharmacopoeia (EP) Reference Standard
Supelco
(±)-Verapamil hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material